|
26
|
Samsara BioCapital
Palo Alto,
California
|
$11M
|
–
|
–
|
–
|
|
|
27
|
Aisling Capital Management
New York
|
$9.99M
|
–
|
–
|
–
|
|
|
28
|
Northern Trust
Chicago,
Illinois
|
$8.71M
|
+$470K
|
+29,805
|
+6%
|
|
|
29
|
Silverarc Capital Management
Boston,
Massachusetts
|
$8.56M
|
+$66.7K
|
+4,231
|
+0.8%
|
|
|
30
|
|
$7.13M
|
-$136K
|
-8,631
|
-2%
|
|
|
31
|
|
$6.65M
|
+$226K
|
+14,358
|
+4%
|
|
|
32
|
Frazier Life Sciences Management
Palo Alto,
California
|
$6.43M
|
–
|
–
|
–
|
|
|
33
|
Charles Schwab
San Francisco,
California
|
$6.34M
|
+$3.91M
|
+248,235
|
+161%
|
|
|
34
|
Schonfeld Strategic Advisors
New York
|
$6.3M
|
-$569K
|
-36,100
|
-8%
|
|
|
35
|
Verition Fund Management
Greenwich,
Connecticut
|
$5.86M
|
+$596K
|
+37,841
|
+11%
|
|
|
36
|
Perceptive Advisors
New York
|
$5.37M
|
–
|
–
|
–
|
|
|
37
|
Integral Health Asset Management
New York
|
$5.35M
|
+$851K
|
+54,029
|
+19%
|
|
|
38
|
|
$4.25M
|
+$4.25M
|
+269,948
|
New
|
|
|
39
|
Bank of New York Mellon
New York
|
$3.68M
|
+$499K
|
+31,683
|
+16%
|
|
|
40
|
Parkman Healthcare Partners
Stamford,
Connecticut
|
$3.68M
|
-$1.12M
|
-71,217
|
-23%
|
|
|
41
|
Nuveen
Charlotte,
North Carolina
|
$3.48M
|
-$461K
|
-29,290
|
-12%
|
|
|
42
|
HighVista Strategies
Boston,
Massachusetts
|
$3.43M
|
+$4.57K
|
+290
|
+0.1%
|
|
|
43
|
Millennium Management
New York
|
$3.21M
|
+$80.5K
|
+5,111
|
+3%
|
|
|
44
|
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$3.07M
|
-$1.55M
|
-98,122
|
-33%
|
|
|
45
|
|
$2.64M
|
+$106K
|
+6,702
|
+4%
|
|
|
46
|
Acuta Capital Partners
Redwood City,
California
|
$2.53M
|
-$504K
|
-32,000
|
-17%
|
|
|
47
|
Affinity Asset Advisors
New York
|
$2.15M
|
+$574K
|
+36,434
|
+36%
|
|
|
48
|
UBS O'Connor
Chicago,
Illinois
|
$1.78M
|
–
|
–
|
–
|
|
|
49
|
Swiss National Bank
Zurich,
Switzerland
|
$1.74M
|
+$150K
|
+9,500
|
+9%
|
|
|
50
|
VOYA Investment Management
Atlanta,
Georgia
|
$1.68M
|
+$1.33M
|
+84,287
|
+375%
|
|
